* IMSTAR *
1985 - IDF
Paris
www.imstar.fr Contract, Services
Key words: Microscopic imaging, Cell screening, Systems, Instruments, High throughput, Pathfinder
Mission: to provide third parties with complete vertical solutions for fully automated high-throughput cellular analysis, in the fields of genotoxicity and environmental toxicity, focused on compound screening, biomonitoring, cytopathology, and dedicated to research, diagnostic, staging and drug discovery
Clients: Research labs
info@imstar.fr
Age: 24 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Spin-off |
Managing Dir.-CEO: Soussaline (Françoise) [born 1945]
Sc.Dir.-CSO: Soussaline (Françoise)
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately owned | Turnover (M€) : 0.5 (2008), 0.77 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Studies
Position : Subcontractor
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME | | 2010 .01 | Partnering research agreement, Biotype, with Sanofi Aventis and 4 academic labs, CEA, Institut Pasteur, Armines and Assitance Publique-Hôpitaux de Paris (AP-HP), to develop new approaches in prostate cancer (completed after 30 months) | R&D | [24 years] |
| 2008 .10 | Research : publication in Mutagenesis with validation of the automated scoring for Micronucleus assay using IMSTAR Pathfinder technology on human lymphocytes | R&D | [23 years] |
| 2008 .05 | Partnering distribution agreement with Naturegene for China market | MKTG | [22 years] |
| 1997 .00 | Launch of Pathfinder, for automated digital imaging | MKTG | [11 years] |
| 1985 .09 | Company founded by Françoise Soussaline, as a spin-off from CEA | ORGF | [0 year] | Actualisation / Updating: 05-Feb-2010 |
|
